the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-25

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluating any possible relationship between irritable bowel syndrome occurrence and Helicobacter pylori infection

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study

NCT04512898

Irritable Bowel Syndrome

UNKNOWN PHASE4

The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicobacter Pylori Infection

NCT04319991

Bowel Dysfunction Helicobacter Pylori Infection

UNKNOWN NA

Prevalence of Intestinal Parasitic Infections in Patients With Irritable Bowel Syndrome

NCT05830370

Irritable Bowel Syndrome

UNKNOWN

Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia

NCT00956397

Functional Dyspepsia Small Intestinal Bacterial Overgrowth Chronic Abdominal Discomfort

COMPLETED NA

Assessment of Psychological Symptoms and Health Related Quality of Life in Patients With Irritable Bowel Syndrome

NCT05480059

IBS - Irritable Bowel Syndrome

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

patients with Irritable Bowel Syndrome

H. pylori stool antigen

Intervention Type DIAGNOSTIC_TEST

using H. pylori antigen kits in stool

Group 2

normal

H. pylori stool antigen

Intervention Type DIAGNOSTIC_TEST

using H. pylori antigen kits in stool

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

H. pylori stool antigen

using H. pylori antigen kits in stool

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients will be selected according to Rome IV criteria for the diagnosis of IBS, which include:

Recurrent abdominal pain at least 1 day/week in the last 3 months, with two or more of the following criteria:

* Related to defecation
* Associated with a change in frequency of stool
* Associated with a change in form of stool. Criteria achieved for the last 3 months with symptom onset at least 6 months before diagnosis

Exclusion Criteria

* • Rectal bleeding

* Anemia
* Weight loss
* Onset after 50 years of age
* Recent antibiotic use
* Abnormal abdominal examination (organomegaly, lump)
* Family history of colorectal cancer.
* Family history of inflammatory bowel disease, or celiac disease.

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes